BioLife Solutions, Inc. Diluted Shares Outstanding (Weighted Average)
BioLife Solutions, Inc. (BLFS) reported Diluted Shares Outstanding (Weighted Average) of 49.29 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-06
- BioLife Solutions, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 49.29M shares, a 3.13% increase year-over-year.
- BioLife Solutions, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 49.25M shares, a 1.82% increase year-over-year.
- BioLife Solutions, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 51.71M shares, a 10.85% increase year-over-year.
- BioLife Solutions, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 48.72M shares, a 5.52% increase year-over-year.
- BioLife Solutions, Inc. weighted average number of shares outstanding, diluted for fiscal 2025 was 48.65M shares, a 5.60% increase from fiscal 2024.
- BioLife Solutions, Inc. weighted average number of shares outstanding, diluted for fiscal 2024 was 46.07M shares, a 5.37% increase from fiscal 2023.
- BioLife Solutions, Inc. weighted average number of shares outstanding, diluted for fiscal 2023 was 43.72M shares, a 1.50% increase from fiscal 2022.
- BioLife Solutions, Inc. weighted average number of shares outstanding, diluted for fiscal 2022 was 43.07M shares, a 11.87% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 12 month | Weighted Average Number of Shares Outstanding, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 49.29M shares 10-Q · filed 2026-08-06 | 49.26M shares 10-Q · filed 2026-08-06 | 50.09M shares derived: average of 3 quarters · filed 2026-08-06 | 49.75M shares derived: average of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | 49.25M shares 10-Q · filed 2026-05-07 | 50.48M shares derived: average of 2 quarters · filed 2026-05-07 | 49.90M shares derived: average of 3 quarters · filed 2026-05-07 | 49.37M shares derived: average of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | 51.71M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 50.22M shares derived: average of 2 quarters · filed 2026-02-26 | 49.41M shares derived: average of 3 quarters · filed 2026-08-06 | 48.65M shares 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | 48.72M shares 10-Q · filed 2025-11-06 | 48.26M shares derived: average of 2 quarters · filed 2026-08-06 | 47.62M shares 10-Q · filed 2025-11-06 | 47.89M shares derived: average of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | 47.80M shares 10-Q · filed 2026-08-06 | 47.47M shares 10-Q · filed 2026-08-06 | 47.61M shares derived: average of 3 quarters · filed 2026-08-06 | 47.25M shares derived: average of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | 48.37M shares 10-Q · filed 2026-05-07 | 47.13M shares 10-Q · filed 2025-05-08 | 47.51M shares derived: average of 2 quarters · filed 2026-05-07 | 47.07M shares derived: average of 3 quarters · filed 2026-05-07 | 46.80M shares derived: average of 4 quarters · filed 2026-05-07 | |||
| 2024-12-31 | 46.65M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 46.41M shares derived: average of 2 quarters · filed 2026-02-26 | 46.28M shares derived: average of 3 quarters · filed 2026-02-26 | 46.07M shares 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | 46.18M shares 10-Q · filed 2025-11-06 | 46.09M shares derived: average of 2 quarters · filed 2025-11-06 | 45.87M shares 10-Q · filed 2025-11-06 | 45.61M shares derived: average of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-30 | 46.00M shares 10-Q · filed 2025-08-07 | 45.72M shares 10-Q · filed 2025-08-07 | 45.42M shares derived: average of 3 quarters · filed 2026-02-26 | 44.96M shares derived: average of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-31 | 45.43M shares 10-Q · filed 2025-05-08 | 45.13M shares derived: average of 2 quarters · filed 2026-02-26 | 44.61M shares derived: average of 3 quarters · filed 2026-02-26 | 44.32M shares derived: average of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | 44.83M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 44.20M shares derived: average of 2 quarters · filed 2026-02-26 | 43.95M shares derived: average of 3 quarters · filed 2026-02-26 | 43.72M shares 10-K · filed 2026-02-26 | ||||
| 2023-09-30 | 43.57M shares 10-Q · filed 2024-11-12 | 43.51M shares derived: average of 2 quarters · filed 2024-11-12 | 43.35M shares 10-Q · filed 2024-11-12 | 43.80M shares derived: average of 4 quarters · filed 2025-03-03 | ||||
| 2023-06-30 | 43.44M shares 10-Q · filed 2024-08-09 | 43.24M shares 10-Q · filed 2024-08-09 | 43.88M shares derived: average of 3 quarters · filed 2025-03-03 | 43.57M shares derived: average of 4 quarters · filed 2025-03-03 | ||||
| 2023-03-31 | 43.03M shares 10-Q · filed 2024-05-10 | 44.10M shares derived: average of 2 quarters · filed 2025-03-03 | 43.61M shares derived: average of 3 quarters · filed 2025-03-03 | 43.33M shares derived: average of 4 quarters · filed 2025-03-03 | ||||
| 2022-12-31 | 45.16M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | 43.91M shares derived: average of 2 quarters · filed 2025-03-03 | 43.42M shares derived: average of 3 quarters · filed 2025-03-03 | 43.07M shares 10-K · filed 2025-03-03 | 42.48M shares 10-K · filed 2024-02-29 | |||
| 2022-09-30 | 42.65M shares 10-Q · filed 2023-11-09 | 42.55M shares derived: average of 2 quarters · filed 2023-11-09 | 42.38M shares 10-Q · filed 2023-11-09 | |||||
| 2022-06-30 | 42.46M shares 10-Q · filed 2023-08-09 | 42.24M shares 10-Q · filed 2023-08-09 | ||||||
| 2021-12-31 | 34.06M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | 38.68M shares derived: average of 2 quarters · filed 2024-02-29 | 39.25M shares derived: average of 3 quarters · filed 2024-02-29 | 38.50M shares 10-K · filed 2024-02-29 | ||||
| 2021-09-30 | 43.30M shares 10-Q · filed 2022-11-09 | 41.84M shares derived: average of 2 quarters · filed 2022-11-09 | 39.98M shares 10-Q · filed 2022-11-09 | |||||
| 2021-06-30 | 40.39M shares 10-Q · filed 2022-08-09 | 38.28M shares 10-Q · filed 2022-08-09 | ||||||
| 2020-09-30 | 31.64M shares 10-Q · filed 2021-11-15 | 27.47M shares derived: average of 2 quarters · filed 2021-11-15 | 29.41M shares 10-Q · filed 2021-11-15 | |||||
| 2020-06-30 | 23.29M shares 10-Q · filed 2021-08-16 | 27.01M shares 10-Q · filed 2021-08-16 | ||||||
| 2020-03-31 | 21.01M shares 10-Q · filed 2020-05-29 | |||||||
| 2019-09-30 | 25.34M shares 10-Q · filed 2020-11-09 | 24.94M shares derived: average of 2 quarters · filed 2020-11-09 | 19.07M shares 10-Q · filed 2020-11-09 | 24.71M shares 10-Q · filed 2019-11-12 | 27.11M shares derived: average of 4 quarters · filed 2020-11-09 | |||
| 2019-06-30 | 24.54M shares 10-Q · filed 2020-08-10 | 18.73M shares 10-Q · filed 2020-08-10 | 24.44M shares 10-Q · filed 2019-08-09 | 27.70M shares derived: average of 3 quarters · filed 2020-08-10 | 25.10M shares derived: average of 4 quarters · filed 2020-08-10 | |||
| 2019-03-31 | 18.65M shares 10-Q · filed 2020-05-29 | 24.36M shares 10-Q · filed 2019-05-09 | 29.29M shares derived: average of 2 quarters · filed 2020-05-29 | 25.28M shares derived: average of 3 quarters · filed 2020-05-29 | 22.76M shares derived: average of 4 quarters · filed 2020-05-29 | |||
| 2018-12-31 | 39.92M shares derived: 10-K 12 month − 10-K 9 month · filed 2019-03-15 | 28.60M shares derived: average of 2 quarters · filed 2020-05-15 | 24.13M shares derived: average of 3 quarters · filed 2020-05-15 | 21.63M shares 10-K · filed 2019-03-15 | ||||
| 2018-09-30 | 17.27M shares 10-K · filed 2020-05-15 | 23.66M shares 10-Q · filed 2018-11-08 | 16.23M shares derived: average of 2 quarters · filed 2020-05-15 | 15.53M shares 10-K · filed 2020-05-15 | 21.05M shares 10-Q · filed 2018-11-08 | 15.08M shares derived: average of 4 quarters · filed 2020-05-15 | ||
| 2018-06-30 | 15.18M shares 10-K · filed 2020-05-15 | 20.37M shares 10-Q · filed 2018-08-09 | 14.64M shares 10-K · filed 2020-05-15 | 19.06M shares 10-Q · filed 2018-08-09 | 14.34M shares derived: average of 3 quarters · filed 2020-05-15 | 14.07M shares derived: average of 4 quarters · filed 2020-05-15 | ||
| 2018-03-31 | 14.10M shares 10-K · filed 2020-05-15 | 13.92M shares derived: average of 2 quarters · filed 2020-05-15 | 13.70M shares derived: average of 3 quarters · filed 2020-05-15 | 13.55M shares derived: average of 4 quarters · filed 2020-05-15 | ||||
| 2017-12-31 | 13.75M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | 13.49M shares derived: average of 2 quarters · filed 2019-03-15 | 13.36M shares derived: average of 3 quarters · filed 2019-03-15 | 13.26M shares 10-K · filed 2019-03-15 | ||||
| 2017-09-30 | 13.24M shares 10-Q · filed 2018-11-08 | 13.17M shares derived: average of 2 quarters · filed 2018-11-08 | 13.10M shares 10-Q · filed 2018-11-08 | |||||
| 2017-06-30 | 13.10M shares 10-Q · filed 2018-08-09 | 13.03M shares 10-Q · filed 2018-08-09 | ||||||
| 2013-12-31 | 5.01M shares 10-K · filed 2014-02-12 | |||||||
| 2012-12-31 | 4.98M shares 10-K · filed 2014-02-12 | 69.68M shares 10-K · filed 2013-03-29 | ||||||
| 2011-12-31 | 69.68M shares 10-K · filed 2013-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |